| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/20/1997 | US5631402 Process for preparing aminobenzoic acid derivatives |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631269 Pyrazole, isooxazole or isothiazole piperidine derivatives |
| 05/20/1997 | US5631265 Chemical intermediates with central nervous system activity |
| 05/20/1997 | US5631260 Xanthine epoxides as A1 adenosine receptor agonists and antagonists |
| 05/20/1997 | US5631257 Benzoxazole derivatives |
| 05/20/1997 | US5631023 Method for making freeze dried drug dosage forms |
| 05/20/1997 | US5631022 Picosulfate dosage form |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997001640A3 Vaccines against hepatitis c |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773025A1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0772614A1 Halogenated imidazopyridines |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772604A1 Triazole compounds and their use as dopamine-d 3?-ligands |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0603305B1 Use of a thymosin in the treatment of hepatitis c |
| 05/14/1997 | EP0441852B1 Muscarinic receptor antagonists |
| 05/14/1997 | CN1149877A Novel elastase inhibitor |
| 05/14/1997 | CN1149869A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity |
| 05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
| 05/14/1997 | CN1149489A Recovering powder for hepatitis B |
| 05/14/1997 | CN1149478A Concentrated powder for colitis |
| 05/14/1997 | CN1149418A Seasoning powder |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |
| 05/13/1997 | US5629329 Methods for treating disorders associated with the central nervous system using opticallly pure (+) cisapride |
| 05/13/1997 | US5629328 Antiemetic agent |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629309 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/13/1997 | US5629305 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 05/13/1997 | US5629297 Administering ranitidine bismuth citrate and helicobacter inhibiting antibiotics |
| 05/13/1997 | US5629292 Use of angiotensin III and analogs thereof in tissue repair |
| 05/13/1997 | US5629026 Gastric disorders |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 05/09/1997 | WO1997016433A1 Protease inhibitors |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/07/1997 | EP0771798A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771207A1 Use of magnesium hydroxide as a stool softener |
| 05/07/1997 | EP0712398B1 Benzopyrans and pharmaceutical compositions containing them |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0238553B1 Method of treating catabolic dysfunction |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/07/1997 | CN1148969A Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing |
| 05/07/1997 | CN1148958A Pharmaceutical application of glucoside A and B of auricledleaf swallowort |
| 05/07/1997 | CN1034810C 1,3-oxathiolane nucleoside analogues |
| 05/06/1997 | US5627203 Tricyclic oxime ethers |
| 05/06/1997 | US5627160 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 05/06/1997 | US5626838 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 05/06/1997 | CA2032394C Multiple encapsulated sweetener delivery system and method of preparation |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770077A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 05/02/1997 | EP0770074A1 Anti-helicobacter acyl derivatives of azolones |
| 05/02/1997 | EP0770073A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 05/02/1997 | EP0770071A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769964A2 Cck antibodies used to improve feed efficiency |
| 05/02/1997 | EP0769953A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769946A1 Methods of maintaining teeth and oral bone |
| 05/02/1997 | EP0707571B1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 05/02/1997 | EP0623024B1 Pharmaceutical bacteriocin compositions and their use for treating gastrointestinal disorders |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015596A1 Human pec-60-like protein and dna encoding the same |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015327A1 Methods of treating established colitis using antibodies against il-12 |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015297A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235402A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/30/1997 | CN1148497A Medicine for treatment of renal lithiasis, liver and gall lithiasis |